HC Wainwright Weighs in on Talphera FY2029 Earnings
Stock analysts at HC Wainwright issued their FY2029 earnings estimates for shares of Talphera in a research note issued on ...
HC Wainwright Issues Optimistic Forecast for CATX Earnings
Stock analysts at HC Wainwright boosted their Q2 2025 EPS estimates for Perspective Therapeutics in a research note issued on ...
Fintel on MSN2d
HC Wainwright & Co. Initiates Coverage of Kairos Pharma (KAPA) with Buy Recommendation
Fintel reports that on April 3, 2025, HC Wainwright & Co. initiated coverage of Kairos Pharma (NYSEAM:KAPA) with a Buy ...
Fintel on MSN3d
HC Wainwright & Co. Upgrades Sarepta Therapeutics (SRPT)
Fintel reports that on April 2, 2025, HC Wainwright & Co. upgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) ...
Kalkine Media3d
Could HC Wainwright's Appraisal Backfire on Cabaletta Bio?
Highlights,Cabaletta Bio receives a favorable evaluation from HC Wainwright.,An institutional review brings renewed focus to ...
H.C. Wainwright sees increased uncertainty for Sarepta franchise
H.C. Wainwright sees increased uncertainty for Sarepta’s Elevidys franchise after the European Medicines Agency placed a clinical hold on three drug trials. The clinical hold on ...
Correction: Galaxy Digital price target lowered to C$30 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Galaxy Digital (BRPHF) to C$30 from C$35 and kept a Buy rating on the shares ...
Kalkine Media3d
Vanda Pharmaceuticals (NASDAQ:VNDA) has been given a Buy rating by HC Wainwright.
Highlights,Vanda Pharmaceuticals posts improved earnings, surpassing market expectations.,Company executives increase stock ...
Sarepta/Roche Suspend Elevidys Gene Therapy Trials In Europe After Patient Death
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved ...
Investing9d
Nektar at H.C. Wainwright Conference: Strategic Updates on Respegg Trials
On Thursday, 27 March 2025, Nektar Therapeutics (NASDAQ: NKTR) participated in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference. The company provided a strategic ...
Nasdaq17d
HC Wainwright & Co. Initiates Coverage of Rezolve AI (RZLV) with Buy Recommendation
Fintel reports that on April 1, 2025, HC Wainwright & Co. initiated coverage of Rezolve AI (NasdaqGM:RZLV) with a Buy recommendation. As of March 19, 2025, the average one-year price target for ...